buprenorphine 2 MG naloxone 0.5 MG Sublingual Tablet
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and are indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
Actavis Pharma, Inc.
ROUND WHITE D 154
D 154 ROUND WHITE
Related Pills
buprenorphine 2 MG naloxone 0.5 MG Sublingual Tablet
Actavis Pharma, Inc.
buprenorphine and naloxone tablet
actavis pharma, inc.
Buprenorphine 8 MG Naloxone 2 MG Sublingual Tablet
Actavis Elizabeth LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED / STORAGE AND HANDLING
BUPRENORPHINE AND NALOXONE sublingual tablets, USP are available as follows: 2 mg/0.5 mg – white to off-white, round tablet debossed with on one side and 154 on the other side supplied in bottles of 30 tablets (NDC 0228-3154-03) with a child-resistant closure. 8 mg/2 mg – white to off-white, round tablet debossed with on one side and 155 on the other side supplied in bottles of 30 tablets (NDC 0228-3155-03) with a child-resistant closure. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in USP. Store
BUPRENORPHINE AND NALOXONE sublingual tablets, USP securely and dispose of properly [see Patient Counseling Information ( 17 )] . round tablet round tablet
More pills like ROUND D 154